TASS on the partnership between PHARM AID and Serum Institute: Localization of vaccine production as a way to achieve technological sovereignty

March 27, 2026

The TASS publication observes the strategy of international technology alliances in pharmaceuticals using the example of PHARM AID's cooperation with the Serum Institute of India in India. The partnership has gone beyond import supplies: the Indian side is transferring documentation, quality standards, and training specialists. The key result is the construction of a full-cycle plant in the Kaluga region with a capacity of more than 20 million doses per year, which will ensure stable supplies and availability of vaccines, including the pentavalent vaccine against meningococcal infection. The project is supported at the regional level and aims to strengthen the resilience of the Russian healthcare system.

https://tass.ru/obschestvo/26900233

The company has established a pharmacovigilance system in accordance with Russian and international requirements.

If you become aware of an adverse reaction associated with the use of our product, please report it to us by any convenient means.

  • Fill out the feedback form on our website
  • By calling the toll-free hotline +7 (800) 350-80-24
  • By email pv@pharmaid.com

By entering your contact details and clicking the 'send' button, you confirm your consent to the processing of your personal data, in accordance with Federal Law No. 152-FZ of July 27, 2006 'On Personal Data,' under the conditions and for the purposes specified in the Consent for Personal Data Processing.